FDA Defends Ephedra Ban Procedures In Nutraceutical Case Filing
This article was originally published in The Tan Sheet
Executive Summary
FDA followed required rulemaking procedures in issuing a final rule that banned ephedra dietary supplements, the agency argues in a response brief filed in its ongoing legal battle with Nutraceutical Corp
You may also be interested in...
Consumer Groups Uneasy, FDA Cautious Over Nanotech In Supplements
Nanotechnology applications in dietary supplements and food additives demand FDA's immediate attention and guidance, consumer advocates say. Agency officials and industry groups, however, tend to support a more measured approach and show fewer signs of concern about nano products
Consumer Groups Uneasy, FDA Cautious Over Nanotech In Supplements
Nanotechnology applications in dietary supplements and food additives demand FDA's immediate attention and guidance, consumer advocates say. Agency officials and industry groups, however, tend to support a more measured approach and show fewer signs of concern about nano products
Consumer Groups Uneasy, FDA Cautious Over Nanotech In Supplements
Nanotechnology applications in dietary supplements and food additives demand FDA's immediate attention and guidance, consumer advocates say. Agency officials and industry groups, however, tend to support a more measured approach and show fewer signs of concern about nano products